CHAMGAP
VERIFIEDPassed the Codex final verification and publication gate. Evidence-verification cutoff: 2026-09-07. AI was used for research and drafting; the existence of all 2 cited sources was verified (1 access-limited, verified via index/summary and marked), followed by blind grading, adversarial audit, and build validation. Methodology v0.9.
Verdict No. 3001 · Search date 2026-09-07 · Methodology v0.9

Daily 10-minute alternate-nostril breathing after two minutes of abdominal breathing,
does it really help with Lower six-week systolic pressure in treated adults with hypertension?

30-Second Summary
C
Evidence Grade C · 50 · Safety caution
A short adjunctive SBP signal, not evidence for a stand-alone effect or medication replacement
Stop if hyperventilation, dizziness, or distress occurs. This trial does not support reducing or stopping antihypertensive medication.
What the
research shows
Grade C with 50 points. In a trial with 91 randomized and 68 completing, six-week systolic pressure was 139.14±12.5 versus 147.79±12.8 mmHg, P<.01. Attrition was 25.3%, and the intervention was not alternate-nostril breathing alone: two minutes of abdominal breathing preceded ten minutes of Nadi Shodhana.
What the
ads claim
Alternate-nostril breathing alone is portrayed as replacing antihypertensive medication or normalizing autonomic function.
*

Useful facts when choosing a product

  • The first two of 12 minutes were abdominal breathing.
  • It was added to ongoing medication and lifestyle care.
  • Sixty-eight of 91 randomized participants completed.
Gap Measurement · Verdict 3001 · C 50
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Adults with hypertension received standard management with or without the breathing program. The program combined two minutes of abdominal breathing with ten minutes of Nadi Shodhana; other pranayama or yoga programs were excluded.

02

Why this is classified as C (50)

One short SBP signal is limited by a surrogate endpoint, combined intervention, 25.3% attrition, small sample, and uncertain prespecification, giving C with 50 points.

Counterpoint. DBP was null between groups, and acute HRV studies were not counted as replication of six-week pressure effects.

Rejudgment record. Cross-check applied — Distinguished final SBP from adjusted change, DBP from HRV, and alternate-nostril breathing alone from the combined abdominal-breathing protocol

Scoring profile behind this grade
EndpointSSurrogate marker - laboratory or imaging measures
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeEXThe clinical size of the effect could not be judged

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Six-week SBP reduction as an adjunctCFinal values differed, but adjusted effect and CI were unavailable.
Improved DBP or HRVDDBP was null and HRV varied by metric and study.

Cross-check — AI research and Codex final gate

AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Randomized adjunct-to-standard-management trial68Reported public/academic supportSix-week SBP, DBP, and HRVSBP 139.14±12.5 vs 147.79±12.8, P<.01; DBP P>.05Key six-week trial
Study 2Acute comparison with another pranayama100Academic researchAcute HRVBetween-group HRV was nullIndirect HRV qualifier
§

Receipt — 2 References

Of 2 cited sources, 1 had limited original-page access (blocked or summary-only) and were verified via index/summary, marked partial; the rest were verified at the original page. As of 2026-09-07.

Mittal G, et al. An Exploratory Randomised Trial to Assess the Effect of Nadi Shodhan Pranayama as an Adjunct Versus Standard Non-pharmacological Management in Hypertensives. Ann Neurosci. 2025. PMID: 40242728. PMCID: PMC11996816. DOI: 10.1177/09727531251318810.
partial
Ghiya S, et al. Comparison of the effects of Nadi Shodhana Pranayama and Bhramari Pranayama on heart rate variability. J Ayurveda Integr Med. 2023. PMID: 37499590. PMCID: PMC10388195. DOI: 10.1016/j.jaim.2023.100774.
checked
Research and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Verification cutoff: 2026-09-07 · Corrections: none

Cite this verdict

Adjunct Alternate-Nostril Breathing for Six-Week Systolic Pressure—Combined Breathing and High Attrition Evidence Grade C card
[Chamgap] Adjunct Alternate-Nostril Breathing for Six-Week Systolic Pressure—Combined Breathing and High Attrition — Evidence Grade C·50. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/heart/alternate-nostril-breathing-adjunct-resting-systolic-pressure/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.